Alnajashi, Hind. “Rituximab As an off Label, High Efficacy Therapy in The Treatment of Multiple Sclerosis and Related Central Nervous System Demyelinating Diseases: Single Centre Experience and Literature Review”. Journal of Contemporary Medical Sciences 11, no. 3 (June 26, 2025). Accessed May 19, 2026. https://jocms.org/index.php/jcms/article/view/1892.